What is the maximum duration a covered esophageal metal stent should remain in place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Duration of Covered Esophageal Metal Stent

For benign esophageal conditions (strictures, perforations, leaks), covered self-expanding metal stents should be removed at a maximum of 3 months, with optimal duration typically between 4-8 weeks, to prevent stent embedding and associated complications. 1

Context-Specific Duration Recommendations

Benign Esophageal Disease (Refractory Strictures, Perforations, Leaks)

The 2018 UK guidelines on esophageal dilatation provide the most recent and authoritative guidance for benign conditions 1:

  • Standard duration: 4-8 weeks for most refractory benign strictures
  • Absolute maximum: 3 months - stents should NOT be left longer due to embedding risk
  • Extended duration (up to 3 months) may be required for particularly challenging strictures, but this represents the upper limit

Critical caveat: The duration may vary based on:

  • Stricture length (longer strictures >7 cm have 69% recurrence rates even after stent removal)
  • Stricture etiology (anastomotic vs. peptic vs. radiation-induced)
  • Type of stent used (fully covered vs. partially covered)

For perforations and anastomotic leaks, research evidence supports 8 weeks as optimal duration for healing 2, with clinical success rates of 76-91% when stents are placed for 5-6 weeks 3.

Malignant Esophageal Disease

For malignant obstruction, the situation differs fundamentally - these stents are typically permanent palliative devices that remain until death or require replacement due to complications 4. The 2002 guidelines note that late morbidity occurs in approximately 25% of patients with metal stents due to tumor ingrowth, overgrowth, migration, or obstruction, but removal is not routinely performed 4.

Stent Type Considerations

Use fully covered self-expanding metal stents (FCSEMS) for benign disease - they lack tissue embedment and are easier to remove compared to partially covered stents 1, 5. Partially covered stents that become embedded require the stent-in-stent technique for removal 5.

Key Complications of Prolonged Placement

Leaving stents beyond recommended timeframes risks:

  • Tissue embedment (making removal difficult or impossible)
  • Stent migration (occurs in ~30% of cases with covered stents) 1
  • Tissue hyperplasia and stricture formation 2
  • Perforation, hemorrhage, and fistula formation (particularly with prior radiation/chemotherapy) 4

Bottom line: For benign disease, plan stent removal at 4-8 weeks, never exceed 3 months. For malignant disease, stents remain indefinitely as palliative therapy unless complications necessitate intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.